172 related articles for article (PubMed ID: 36321974)
21. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity.
Muñoz M; López-Oliva ME; Rodríguez C; Martínez MP; Sáenz-Medina J; Sánchez A; Climent B; Benedito S; García-Sacristán A; Rivera L; Hernández M; Prieto D
Redox Biol; 2020 Jan; 28():101330. PubMed ID: 31563085
[TBL] [Abstract][Full Text] [Related]
22. NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.
Di Marco E; Gray SP; Kennedy K; Szyndralewiez C; Lyle AN; Lassègue B; Griendling KK; Cooper ME; Schmidt HHHW; Jandeleit-Dahm KAM
Free Radic Biol Med; 2016 Aug; 97():556-567. PubMed ID: 27445103
[TBL] [Abstract][Full Text] [Related]
23. Apocynin ameliorates NADPH oxidase 4 (NOX4) induced oxidative damage in the hypoxic human retinal Müller cells and diabetic rat retina.
Ahmad A; Nawaz MI; Siddiquei MM; Abu El-Asrar AM
Mol Cell Biochem; 2021 May; 476(5):2099-2109. PubMed ID: 33515385
[TBL] [Abstract][Full Text] [Related]
24. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
25. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
26. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
Thallas-Bonke V; Tan SM; Lindblom RS; Snelson M; Granata C; Jha JC; Sourris KC; Laskowski A; Watson A; Tauc M; Rubera I; Zheng G; Shah AM; Harris DCH; Elbatreek MH; Kantharidis P; Cooper ME; Jandeleit-Dahm K; Coughlan MT
Nephrol Dial Transplant; 2021 May; 36(6):988-997. PubMed ID: 33367789
[TBL] [Abstract][Full Text] [Related]
27. TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy.
Kowluru RA; Kowluru A; Veluthakal R; Mohammad G; Syed I; Santos JM; Mishra M
Diabetologia; 2014 May; 57(5):1047-56. PubMed ID: 24554007
[TBL] [Abstract][Full Text] [Related]
28. Subcellular localization of Nox4 and regulation in diabetes.
Block K; Gorin Y; Abboud HE
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14385-90. PubMed ID: 19706525
[TBL] [Abstract][Full Text] [Related]
29. Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.
Appukuttan B; Ma Y; Stempel A; Ashander LM; Deliyanti D; Wilkinson-Berka JL; Smith JR
Clin Exp Ophthalmol; 2018 Aug; 46(6):652-660. PubMed ID: 29360265
[TBL] [Abstract][Full Text] [Related]
30. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells.
Basuroy S; Bhattacharya S; Leffler CW; Parfenova H
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C422-32. PubMed ID: 19118162
[TBL] [Abstract][Full Text] [Related]
31. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
Schröder K; Zhang M; Benkhoff S; Mieth A; Pliquett R; Kosowski J; Kruse C; Luedike P; Michaelis UR; Weissmann N; Dimmeler S; Shah AM; Brandes RP
Circ Res; 2012 Apr; 110(9):1217-25. PubMed ID: 22456182
[TBL] [Abstract][Full Text] [Related]
32. Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1/Nox4 signal pathway in diabetic rats.
Su J; An XR; Li Q; Li XX; Cong XD; Xu M
Sci Rep; 2018 Aug; 8(1):12620. PubMed ID: 30135489
[TBL] [Abstract][Full Text] [Related]
33. ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22
Sun J; Chen J; Li T; Huang P; Li J; Shen M; Gao M; Sun Y; Liang J; Li X; Wang Y; Xiao Y; Shi X; Hu Y; Feng J; Jia H; Liu T; Sun X
Theranostics; 2020; 10(25):11637-11655. PubMed ID: 33052238
[No Abstract] [Full Text] [Related]
34. NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro.
Wang J; Hong Z; Zeng C; Yu Q; Wang H
Free Radic Biol Med; 2014 Apr; 69():278-88. PubMed ID: 24480752
[TBL] [Abstract][Full Text] [Related]
35. Role of NADPH oxidase in retinal vascular inflammation.
Al-Shabrawey M; Rojas M; Sanders T; Behzadian A; El-Remessy A; Bartoli M; Parpia AK; Liou G; Caldwell RB
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3239-44. PubMed ID: 18378574
[TBL] [Abstract][Full Text] [Related]
36. Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I.
Xi G; Shen XC; Wai C; Clemmons DR
J Biol Chem; 2013 May; 288(22):15641-53. PubMed ID: 23612968
[TBL] [Abstract][Full Text] [Related]
37. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.
Kim YM; Kim SJ; Tatsunami R; Yamamura H; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C749-C764. PubMed ID: 28424170
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
[TBL] [Abstract][Full Text] [Related]
39. NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.
Meng D; Mei A; Liu J; Kang X; Shi X; Qian R; Chen S
PLoS One; 2012; 7(10):e48393. PubMed ID: 23144758
[TBL] [Abstract][Full Text] [Related]
40. Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.
Rojas M; Zhang W; Xu Z; Lemtalsi T; Chandler P; Toque HA; Caldwell RW; Caldwell RB
PLoS One; 2013; 8(12):e84357. PubMed ID: 24358357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
